Quick Answer
HealthLynked Corp reported Total Revenue of $3.01 million for fiscal year 2024.
HealthLynked Corp — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | — | $3.01M -47.4% |
$5.72M -2.3% |
$5.86M -9.8% |
$6.50M +5.9% |
$6.13M +52.6% |
| Net Income | -$3.28M +46.5% |
-$6.13M -505.8% |
-$1.01M +88.5% |
-$8.82M +15.3% |
-$10.41M -80.9% |
-$5.76M -4.1% |
| Diluted EPS | -$1.16 +46.8% |
-$2.18 | $0.00 +100.0% |
-$0.04 +20.0% |
-$0.05 -25.0% |
-$0.04 +33.3% |
| Total Assets | $1.70M -23.4% |
$2.22M -48.1% |
$4.28M -6.6% |
$4.58M -57.2% |
$10.69M +33.2% |
$8.03M +215.2% |
| Cash and Equivalents | — | $76.2K -69.2% |
$247.2K | — | $3.29M +1929.6% |
$162.2K +46.9% |
| Long-Term Debt | — | — | — | $45.0K -55.6% |
$101.2K | — |
| Stockholders Equity | -$5.76M -84.1% |
-$3.13M -488.9% |
$804.7K +155.9% |
$314.4K -95.6% |
$7.20M +433.6% |
$1.35M +147.5% |
| Operating Income | — | -$4.68M -12.7% |
-$4.15M +52.1% |
-$8.66M -62.4% |
-$5.33M -73.5% |
-$3.07M +4.3% |
| Shares Outstanding | 2.82M +0.0% |
2.82M -99.0% |
275.96M +7.8% |
255.94M +7.6% |
237.89M +26.6% |
187.97M +71.0% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2024 | $590.1K | -55.7% | -25.8% |
| Net Income | September 30, 2025 | -$851.8K | +56.8% | -21.5% |
| Diluted EPS | September 30, 2025 | -$0.30 | +57.1% | — |
| Total Assets | September 30, 2025 | $1.76M | -36.0% | -4.5% |
| Cash and Equivalents | June 30, 2024 | $172.7K | — | -30.1% |
| Long-Term Debt | March 31, 2023 | $37.5K | -63.0% | -16.7% |
| Stockholders Equity | September 30, 2025 | -$5.43M | -181.1% | -14.3% |
| Operating Income | September 30, 2024 | -$1.67M | -41.1% | -54.8% |
| Gross Profit | September 30, 2019 | $885.3K | +64.1% | -0.2% |
| Shares Outstanding | September 30, 2025 | 2.85M | -99.0% | -99.0% |
- HealthLynked Corp reported Total Revenue of $3.01 million for fiscal year 2024.
- HealthLynked Corp showed a decrease of -47.4% in Total Revenue compared to the prior fiscal year.
- HealthLynked Corp reported Net Income of -$3.28 million for fiscal year 2025.
- HealthLynked Corp showed an increase of +46.5% in Net Income compared to the prior fiscal year.
- HealthLynked Corp reported Diluted EPS of $1.16 per share (loss) for fiscal year 2025.
- HealthLynked Corp showed an increase of +46.8% in Diluted EPS compared to the prior fiscal year.
- HealthLynked Corp reported Total Assets of $1.70 million for fiscal year 2025.
- HealthLynked Corp showed a decrease of -23.4% in Total Assets compared to the prior fiscal year.
- HealthLynked Corp reported Cash and Equivalents of $76.2 thousand for fiscal year 2024.
- HealthLynked Corp showed a decrease of -69.2% in Cash and Equivalents compared to the prior fiscal year.
- HealthLynked Corp reported Long-Term Debt of $45.0 thousand for fiscal year 2022.
- HealthLynked Corp showed a decrease of -55.6% in Long-Term Debt compared to the prior fiscal year.
- HealthLynked Corp reported Stockholders Equity of -$5.76 million for fiscal year 2025.
- HealthLynked Corp showed a decrease of -84.1% in Stockholders Equity compared to the prior fiscal year.
- HealthLynked Corp reported Operating Income of -$4.68 million for fiscal year 2024.
- HealthLynked Corp showed a decrease of -12.7% in Operating Income compared to the prior fiscal year.
- HealthLynked Corp reported Shares Outstanding of 2.82 million shares for fiscal year 2025.
- HealthLynked Corp showed an increase of +0.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: